Brief: Elanco Receives Positive Opinion On Zenrelia From EU's Committee
12/06/2025 21:19
June 12 (Reuters) - Elanco Animal Health Inc ELAN.N: ELANCO RECEIVES POSITIVE OPINION ON ZENRELIA (ILUNOCITINIB) FROM EU'S COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS (CVMP) Source text: ID:nPn6jjbtXa Further company coverage: ELAN.N (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Elanco Animal Health Incorporated
See all newsBrief: Elanco Animal Health Appoints Jamie Preston As Chief People Officer
U.S. STOCKS ON THE MOVE-Walt Disney, Alphabet, Kraft Heinz
U.S. STOCKS ON THE MOVE-Wynn Resorts, Griffon, Kratos Defense, Amgen
Elanco Animal Health Incorporated reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-Cencora, Charles River, Twist Bioscience